vs
Side-by-side financial comparison of BLACK HILLS CORP (BKH) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.
BLACK HILLS CORP is the larger business by last-quarter revenue ($241.6M vs $37.2M, roughly 6.5× Organogenesis Holdings Inc.). On growth, BLACK HILLS CORP posted the faster year-over-year revenue change (-3.0% vs -57.1%). Over the past eight quarters, BLACK HILLS CORP's revenue compounded faster (-22.0% CAGR vs -46.5%).
Black Hills Corporation is an American diversified energy company that is an electric and gas utility in South Dakota, Montana, Wyoming, Colorado, Arkansas, Kansas, Nebraska, and Iowa. The company sells power throughout the American West. The company is based in Rapid City, South Dakota. It derives its name from its home in the Black Hills of South Dakota.
Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.
BKH vs ORGO — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $241.6M | $37.2M |
| Net Profit | $133.1M | — |
| Gross Margin | — | 30.8% |
| Operating Margin | 83.6% | -185.1% |
| Net Margin | 55.1% | — |
| Revenue YoY | -3.0% | -57.1% |
| Net Profit YoY | -2.4% | — |
| EPS (diluted) | $1.73 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $241.6M | $37.2M | ||
| Q4 25 | $622.7M | $225.6M | ||
| Q3 25 | $427.4M | $150.9M | ||
| Q2 25 | $435.7M | $101.0M | ||
| Q1 25 | $800.4M | $86.7M | ||
| Q4 24 | $585.1M | $126.7M | ||
| Q3 24 | $398.6M | $115.2M | ||
| Q2 24 | $397.1M | $130.2M |
| Q1 26 | $133.1M | — | ||
| Q4 25 | $104.9M | $43.7M | ||
| Q3 25 | $24.9M | $21.6M | ||
| Q2 25 | $27.5M | $-9.4M | ||
| Q1 25 | $134.3M | $-18.8M | ||
| Q4 24 | $98.0M | $7.7M | ||
| Q3 24 | $24.4M | $12.3M | ||
| Q2 24 | $22.8M | $-17.0M |
| Q1 26 | — | 30.8% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 72.6% | ||
| Q4 24 | — | 75.5% | ||
| Q3 24 | — | 76.7% | ||
| Q2 24 | — | 77.6% |
| Q1 26 | 83.6% | -185.1% | ||
| Q4 25 | 27.5% | 28.1% | ||
| Q3 25 | 18.4% | 13.7% | ||
| Q2 25 | 18.9% | -12.5% | ||
| Q1 25 | 25.6% | -30.9% | ||
| Q4 24 | 27.9% | 8.1% | ||
| Q3 24 | 19.0% | 5.4% | ||
| Q2 24 | 17.8% | -10.7% |
| Q1 26 | 55.1% | — | ||
| Q4 25 | 16.8% | 19.4% | ||
| Q3 25 | 5.8% | 14.3% | ||
| Q2 25 | 6.3% | -9.3% | ||
| Q1 25 | 16.8% | -21.7% | ||
| Q4 24 | 16.7% | 6.1% | ||
| Q3 24 | 6.1% | 10.7% | ||
| Q2 24 | 5.7% | -13.1% |
| Q1 26 | $1.73 | — | ||
| Q4 25 | $1.39 | $0.31 | ||
| Q3 25 | $0.34 | $0.11 | ||
| Q2 25 | $0.38 | $-0.10 | ||
| Q1 25 | $1.87 | $-0.17 | ||
| Q4 24 | $1.36 | $0.05 | ||
| Q3 24 | $0.35 | $0.09 | ||
| Q2 24 | $0.33 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $91.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | — |
| Total Assets | — | $520.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $91.4M | ||
| Q4 25 | $182.8M | $93.7M | ||
| Q3 25 | $21.1M | $63.7M | ||
| Q2 25 | $8.1M | $73.1M | ||
| Q1 25 | $6.6M | $110.0M | ||
| Q4 24 | $16.1M | $135.6M | ||
| Q3 24 | $12.5M | $94.3M | ||
| Q2 24 | $624.8M | $89.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $62.3M | ||
| Q2 24 | — | $63.8M |
| Q1 26 | — | — | ||
| Q4 25 | $3.8B | $300.1M | ||
| Q3 25 | $3.8B | $255.1M | ||
| Q2 25 | $3.6B | $233.2M | ||
| Q1 25 | $3.6B | $242.9M | ||
| Q4 24 | $3.5B | $262.9M | ||
| Q3 24 | $3.4B | $278.5M | ||
| Q2 24 | $3.4B | $263.5M |
| Q1 26 | — | $520.0M | ||
| Q4 25 | $10.9B | $598.7M | ||
| Q3 25 | $10.3B | $509.8M | ||
| Q2 25 | $10.1B | $461.1M | ||
| Q1 25 | $10.1B | $467.4M | ||
| Q4 24 | $10.0B | $497.9M | ||
| Q3 24 | $9.7B | $446.3M | ||
| Q2 24 | $10.2B | $443.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.22× | ||
| Q2 24 | — | 0.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
